ATTMULTI

Serial Number 88038659
606

Registration Progress

Application Filed
Jul 16, 2018
Under Examination
Feb 5, 2019
Approved for Publication
Dec 11, 2018
Published for Opposition
Dec 11, 2018
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: ATTMULTI
Previous Owner: H. Lundbeck A/S
Classes: 005

Trademark Image

ATTMULTI

Basic Information

Serial Number
88038659
Filing Date
July 16, 2018
Published for Opposition
December 11, 2018
Abandonment Date
March 14, 2022
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Mar 14, 2022
Classes
005

Rights Holder

H. Lundbeck A/S

99
Address
Ottiliavej 9
Valby 2500
DK

Ownership History

H. Lundbeck A/S

Original Applicant
99
2500 Valby DK

H. Lundbeck A/S

Owner at Publication
99
Valby DK

Legal Representation

Attorney
Claudia A. Smith

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

32 events
Date Code Type Description Documents
Mar 14, 2022 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Mar 14, 2022 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Jul 13, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 12, 2021 EX5G S SOU EXTENSION 5 GRANTED Loading...
Jun 29, 2021 EXT5 S SOU EXTENSION 5 FILED Loading...
Jul 8, 2021 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Jun 29, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 22, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 20, 2021 EX4G S SOU EXTENSION 4 GRANTED Loading...
Jan 20, 2021 EXT4 S SOU EXTENSION 4 FILED Loading...
Jan 20, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 25, 2020 DOCK D ASSIGNED TO EXAMINER Loading...
Jul 15, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 13, 2020 EX3G S SOU EXTENSION 3 GRANTED Loading...
Jul 13, 2020 EXT3 S SOU EXTENSION 3 FILED Loading...
Jul 13, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 23, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 21, 2020 EX2G S SOU EXTENSION 2 GRANTED Loading...
Jan 21, 2020 EXT2 S SOU EXTENSION 2 FILED Loading...
Jan 21, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 17, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 15, 2019 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jul 15, 2019 EXT1 S SOU EXTENSION 1 FILED Loading...
Jul 15, 2019 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 5, 2019 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Dec 11, 2018 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Dec 11, 2018 PUBO A PUBLISHED FOR OPPOSITION Loading...
Nov 21, 2018 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Oct 30, 2018 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Oct 26, 2018 DOCK D ASSIGNED TO EXAMINER Loading...
Jul 19, 2018 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jul 19, 2018 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of dementia, Alzheimer's disorder and disease, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy; pharmaceutical preparations and substances for the prevention and treatment of Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disorder and disease, insomnia, Parkinson's disorder and disease, falls, movement disorders and diseases, dyskinesia, poor or absent motor functions, tremor, schizophrenia, bipolar disorder and disease, mania, ADHD, PTSD, agitation, aggression, autism, melancholy, OCD, Tourette's syndrome, progressive supranuclear palsy (PSP); pharmaceutical preparations and substances for the prevention and treatment of restlessness, akathisia, fatigue, somnolence, nausea, cancer, migraine, pain, alcoholism and chemical dependency; diagnostic agents, reagents, preparations and substances for medical purposes

Classification

International Classes
005